Benitec Biopharma (BNTC) Return on Assets (2020 - 2025)
Benitec Biopharma (BNTC) posted Return on Assets of 2.06% for Q4 2025, up 49.5% sequentially from 4.09% in Q3 2025, and up 37.0% YoY from 1.51% in Q4 2024.
Benitec Biopharma (BNTC) Return on Assets (2020 - 2025) Analysis & Trends
Benitec Biopharma has reported Return on Assets for 6 years, with the latest figure at 2.06% in Q4 2025.
- Quarterly Return on Assets rose 37.0% year-over-year to 2.06% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 2.06% (up 37.0% YoY) and the FY2025 annual result came in at 1.02%, down 19.0% from the prior year.
- Return on Assets rose to 2.06% in Q4 2025 per BNTC's latest filing, from 4.09% in the prior quarter.
- Over five years, Return on Assets peaked at 0.01% in Q2 2021 and troughed at 4.09% in Q3 2025.
- A 5-year average of 0.62% and a median of 0.02% in 2023 frame the typical range for Return on Assets.
- The widest YoY moves for Return on Assets: up 37 bps in 2025, down 283 bps in 2025.
- Over 5 years, Return on Assets stood at 0.01% in 2021, then declined by 20 bps to 0.01% in 2022, then slumped by 43 bps to 0.02% in 2023, then slumped by 12510 bps to 2.43% in 2024, then grew by 15 bps to 2.06% in 2025.
- According to Business Quant data, Return on Assets over the past three periods registered 2.06%, 4.09%, and 2.43% for Q4 2025, Q3 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.01% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | -2.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.06% |
| Sep 30, 2025 | -4.09% |
| Dec 31, 2024 | -2.43% |
| Sep 30, 2024 | -1.25% |
| Jun 30, 2024 | -0.81% |
| Mar 31, 2024 | -0.22% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.05% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |
| Mar 31, 2021 | -0.02% |
| Dec 31, 2020 | -0.02% |
| Sep 30, 2020 | -0.02% |